References
- AessoposAFarmakisDKaragiorgaMCardiac involvement in thalassemia intermedia: a multicenter studyBlood200197113411341611369631
- PhrommintikulASukonthasarnAKanjanavanitRNawarawongWSplenectomy: a strong risk factor for pulmonary hypertension in patients with thalassaemiaHeart200692101467147216621878
- SonakulDPachareePLaohapandTFucharoenSWasiPPulmonary artery obstruction in thalassaemiaSoutheast Asian J Trop Med Public Health19801145165237221695
- SingerSTKuypersFAStylesLVichinskyEPFooteDRosenfeldHPulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable stateAm J Hematol200681967067516795058
- AtichartakarnVLikittanasombatKChuncharuneeSPulmonary arterial hypertension in previously splenectomized patients with beta-thalassemic disordersInt J Hematol200378213914512953808
- RufAPickMDeutschVIn-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia majorBr J Haematol199798151569233563
- CappelliniMDRobbioloLBottassoBMCoppolaRFiorelliGMannucciAPVenous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermediaBr J Haematol2000111246747311122086
- EldorARachmilewitzEAThe hypercoagulable state in thalassemiaBlood2002991364311756150
- EldorALelloucheFGoldfarbARachmilewitzEAMacloufJIn vivo platelet activation in beta-thalassemia major reflected by increased platelet-thromboxane urinary metabolitesBlood1991778174917532015401
- OpartkiattikulNFunaharaYFucharoenSTalalakPIncrease in spontaneous platelet aggregation in beta-thalassemia/hemoglobin E disease: a consequence of splenectomySoutheast Asian J Trop Med Public Health199323Suppl 2S36S41
- AessoposAFarmakisDDeftereosSThalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermediaChest200512751523153015888823
- ChiewsilpPThe Appropriate Use of Blood and Blood Components Physician Handbook1st edBangkokThai Red Cross Society’s National Blood Center2011
- ATS Committee on Proficiency Standards for Clinical Pulmonary Function LaboratoriesATS statement: guidelines for the six-minute walk testAm J Respir Crit Care Med2002166111111712091180
- RubinLJAmerican College of Chest PhysiciansDiagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelinesChest2004126Suppl 17S10S15249491
- YockPGPoppRLNoninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitationCirculation19847046576626478568
- OttoCMEchocardiographic evaluation of left and right ventricular systolic functionOttoCMTextbook of Clinical Echocardiography2nd edPhiladelphia, PAWB Saunders2000100128
- BarstRJMcGoonMTorbickiADiagnosis and differential assessment of pulmonary arterial hypertensionJ Am Coll Cardiol20044312 Suppl S40S47S15194177
- AtichartakarnVChuncharuneeSChandanamatthaPLikittanasombatKAryurachaiKCorrection of hypercoagulability and amelioration of pulmonary arterial hypertension by chronic blood transfusion in an asplenic hemoglobin E/beta-thalassemia patientBlood200410372844284614645000
- TaherATOtrockZKUthmanICappelliniMDThalassemia and hypercoagulabilityBlood Rev200822528329218511163
- O’DriscollAMackieIJPorterJBMachinSJLow plasma heparin cofactor II levels in thalassaemia syndromes are corrected by chronic blood transfusionBr J Haematol199590165707786797
- FucharoenSYoungchaiyudPWasiPHypoxaemia and the effect of aspirin in thalassaemiaSoutheast Asian J Trop Med Public Health198112190937256361
- RobbinsIMKawutSMYungDA study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertensionEur Respir J200627357858416507859
- AtichartakarnVAngchaisuksiriPAryurachaiKRelationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/beta-thalassaemic patientsBr J Haematol2002118389389812181063